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Introduction: Hypogammaglobulinemia is defined as a
plasmatic level of immunoglobulin G (IgG) under 5
g/L. Although some of them are linked to primary
immune deficiency (PID), majority are secondary
immune deficiency (SID).
Objective: Since there are a few studies about this
subject, we though interesting to precise frequency,
severity, treafinent and outcome of patients with
hypogammaglobulinemia in a large population
including children and adults.
Methods: We performed a retrospective analysis of
336 patients (38 children less than 18 years and 298adults) diagnosed in 2005 with
hypogammaglobulinemia in the University Hospital in
Angers.
Results: Mean IgG level was 4.8 glL and 70 patients
(2lo/o) had a global deficiency (Ig G, A and M). Only
18 (5%) patients with PID were identified (10 common
variable immuno deficiency, 5 congenital deficiencies
and 3 transients hypogammaglobulinemia in infancy).
Others patients (318/336) were considered as SID.
Among them, hypogammaglobulinemia was associated
with nephropathy (16%), myeloma (15%), lymphoma
(15%), chronic lymphocytic leukemia (6%), drug-
related (14 %)(immunosuppressors, antiepileptics,
corticosteroids) or link to other diseases defined (18%).
Finally, 16% of patients remained unclassified. 2lo/o of
patients required immunoglobulin replacement therapy
and l2Yo bone marrow transplantation. During follow-
up, 441231 (19%) patients with SID died (not
necessarily ffom immunodeficiency) while 3/18 (16%)
patients with PID died (generally from
immunodeficiency).
Conclusions: Hypogammaglobulinemia requires a
rigorous diagnosis approach. While majority of
hypogammaglobulinemia in children correspond to
PID, most of them in adults are SID and prognosis
depends on underlying disease.
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Introduction: Cases of CD 19 deficiency from South
East Asia has rarely been reported. A, 1l yr Malay boy
was referred with recurrent infections with 2 episodes
of'chickenpox at age 2 years. He had repeated episodes
of pneumoniae and bronchiectasis by age 6 years.
Physical examination revealed gross clubbing with
crepitations at both lung bases. IV lg administration
was instituted with clinical improvementlaboratory
data: Serum Ig (g/l )IgG 8.37[n 4.95- 16.56 ], IgA
0.92[n 0.30-2.35 7, lgM 0.21 [0.32-1.4}]Lymphocyte
subset (age 1l) CD19 Q o , CD20 11.26% (12-22)CD3
83.64% (n 66-76) ,CD4 36.25 ( 33-41),CD8 41.55 (27-
35), CDl6+56 I1.6 %. (9-16),Specific antibody
response to polysaccharide antigen was impaired ;
whileNBT , lymphocyte proliferation to (PHA ) were
normal, Btk protein 18% (control 87.8 %). Our finding
conforms with a diagnosis of CD19 deficiency with
selective IgM deficiency and partial defective Btk
protein expression. CDl9 deficient B cells with
hypogammaglobulinemia is a rare disorder. Up to 2007
only 5 cases had been reportedl. All the 5 CDl9
deficiency cases reported (Van ZelmMC et L (2006) &
Kanagena H et a1 (2007) lhad more Ihan 2 Ig isotypelevel reduced Our patient with had only Ig
isotype(igM) reduced. The proposed functional
abnormality is the disruption of CD19 signalling
resulting in a primary antibody deficiency mainly
characterised by a poor antigen specific response. Our
findings has added further dimension to elucidation of
the functional abnormality in CDl9 deficiency and
variable isotype immunoglobulin deficiency.
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Introduction: Activation of CVID B cells via TLRT
and TLR9 is impaired. The TLR2 ligand Pam3CSK4
has been shown to activate helper T cells and induce
IFN-y production. The capacity of CVID T cells to
respond to TLR2 co-stimulation has not been examined
yet.
Objective: The aim of the study was to investigate T
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